Fred Alger Management’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14M | Sell |
295,623
-347,258
| -54% | -$16.4M | 0.06% | 145 |
|
|
2025
Q1 | $25.1M | Sell |
642,881
-30,892
| -5% | -$1.21M | 0.14% | 100 |
|
|
2024
Q4 | $36.5M | Buy |
673,773
+7,199
| +1% | +$390K | 0.17% | 88 |
|
|
2024
Q3 | $33.6M | Buy |
666,574
+7,545
| +1% | +$380K | 0.16% | 97 |
|
|
2024
Q2 | $29M | Sell |
659,029
-7,693
| -1% | -$338K | 0.14% | 101 |
|
|
2024
Q1 | $33.5M | Sell |
666,722
-143,864
| -18% | -$7.23M | 0.17% | 112 |
|
|
2023
Q4 | $49M | Sell |
810,586
-22,365
| -3% | -$1.35M | 0.26% | 81 |
|
|
2023
Q3 | $47.5M | Buy |
832,951
+85,346
| +11% | +$4.86M | 0.27% | 91 |
|
|
2023
Q2 | $38.1M | Buy |
747,605
+640,685
| +599% | +$32.7M | 0.19% | 119 |
|
|
2023
Q1 | $2.29M | Buy |
+106,920
| New | +$2.29M | 0.01% | 329 |
|